article thumbnail

Pharmaceutical Patents: A Challenge for Malaysia

Contrarian Sales Techniques

The paper was presented at the International Conference on Pharmaceutical Research and Development (IPRDC) in Kuala Lumpur, Malaysia, in June 2017. It is worth mentioning that the government is the largest pharmaceutical buyer in Malaysia, responsible for more than half of the pharmaceutical purchasing value.

article thumbnail

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

PharmaKinnex

More convenience and safety? On April 18, 2002, the Pharmaceutical Research and Manufacturers of America (PhRMA) adopted a new marketing code to govern the pharmaceutical industry’s relationships with physicians and other health care professionals…” – AMA Journal of Ethics. What’s not to love?

Pharma 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

2022 in review: Regulation starts to catch up with AI in pharma

Pharmaceutical Technology

This could spell high-stake consequences for consumers whose privacy and safety could be at risk if AI models are not regulated. This action was part of the UK’s National AI Strategy of which the third pillar is “Governing AI effectively”. China takes an aim at recommendation algorithms.

Pharma 140
article thumbnail

Primate models in pharma: What the future holds

Pharmaceutical Technology

Pharmaceutical research has long relied on non-human primate models for early-stage discoveries, but their use continues to cause controversy. However, according to the US Food and Drug Administration (FDA), non-human primates are still the most scientifically relevant large model to test biologic drugs for safety.

Pharma 98